Claims
- 1. A compound selected from the group consisting of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, a pharmaceutically acceptable acid addition salt thereof, and an enantiomeric form thereof.
- 2. An antipsychotic composition comprising an inert carrier and as active ingredient an antipsychotic effective amount of a compound selected from the group consisting of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, a pharmaceutically acceptable acid addition salt thereof, and an enantiomeric form thereof.
- 3. A method of treating warm-blooded animals suffering from psychotic diseases, which method comprises the administration to said warm-blooded animals of an antipsychotic effective amount of a compound selected from the group consisting of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, a pharmaceutically acceptable acid addition salt thereof, and an enantiomeric form thereof.
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation-in-part of our copending application U.S. Ser. No. 267,857, filed Nov. 7, 1988 now abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
4485107 |
Kennis et al. |
Nov 1984 |
|
4644000 |
Gauss et al. |
Feb 1987 |
|
4665075 |
Vandenberk et al. |
May 1987 |
|
4804663 |
Kennis et al. |
Feb 1989 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
0196132 |
Oct 1986 |
EPX |
2051048A |
Jan 1981 |
GBX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
267857 |
Nov 1988 |
|